RheoGene, Inc. Adds Internationally Renowned Gene Therapy Experts To Its Scientific Advisory Board
10/19/2005 5:09:04 PM
NORRISTOWN, PA -- (MARKET WIRE) -- 08/02/2005 -- RheoGene Inc. is pleased to announce the addition of three new members to its Scientific Advisory Board. Joining Alan Russell, Ph.D., and Arthur Levine, M.D., are Fred H. Gage, Ph.D., Richard Gregory, Ph.D. and Inder Verma Ph.D. The Board brings exceptional breadth of knowledge and experience in the fields of gene expression, gene and cell therapy, regenerative medicine, cancer, CNS disorders and immunology, all critical to RheoGene's success and direction as the company builds upon its core technology platforms and advances the RheoSwitch® Therapeutic System for cell and gene therapy into the clinic.
comments powered by